Jennison Associates
AGN

Jennison Associates’s Allergan Inc AGN Stock Holding History

Jennison Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,503,939
Closed -$320M – 801
2014
Q4 		$320M Sell
1,503,939
-2,880,356
-66% -$573M 0.3% 72
2014
Q3 		$781M Sell
4,384,295
-103,271
-2% -$17.2M 0.72% 44
2014
Q2 		$759M Sell
4,487,566
-6,176,439
-58% -$962M 0.7% 44
2014
Q1 		$1.32B Sell
10,664,005
-63,031
-0.6% -$7.67M 1.27% 12
2013
Q4 		$1.19B Buy
10,727,036
+1,299,673
+14% +$124M 1.17% 16
2013
Q3 		$853M Buy
9,427,363
+2,669,323
+39% +$240M 0.89% 31
2013
Q2 		$569M Buy
+6,758,040
New +$701M 0.64% 44

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Jennison Associates's AGN Position: Q1 2015 in Review

Jennison Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,503,939 shares — an estimated $320M sold.

Jennison Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.32B in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Jennison Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Jennison Associates sold 1,503,939 Allergan Inc shares in Q1 2015, an estimated $320M.
  • Jennison Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Jennison Associates's Allergan Inc position peaked at $1.32B in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.